Firefly Neuroscience, Inc.
AIFF
$1.73
$0.052.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 29.77% | 595.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 29.77% | 595.35% | |||
| Cost of Revenue | 868.00% | -- | |||
| Gross Profit | -46.72% | 537.21% | |||
| SG&A Expenses | 45.99% | -15.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 50.93% | -10.67% | |||
| Operating Income | -54.92% | 23.29% | |||
| Income Before Tax | -44.29% | 85.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -43.97% | 85.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -43.97% | 85.82% | |||
| EBIT | -54.92% | 23.29% | |||
| EBITDA | -52.40% | 22.58% | |||
| EPS Basic | -35.11% | 91.69% | |||
| Normalized Basic EPS | -28.47% | 89.18% | |||
| EPS Diluted | -35.11% | 91.69% | |||
| Normalized Diluted EPS | -28.47% | 89.18% | |||
| Average Basic Shares Outstanding | 6.54% | 27.23% | |||
| Average Diluted Shares Outstanding | 6.54% | 27.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||